contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.


Arden's Day Blog

Arden's Day is a type I diabetes care giver blog written by author Scott Benner. Scott has been a stay-at-home dad since 2000, he is the author of the award winning parenting memoir, 'Life Is Short, Laundry Is Eternal'. Arden's Day is an honest and transparent look at life with diabetes - since 2007.

type I diabetes, parent of type I child, diabetes Blog, OmniPod, DexCom, insulin pump, CGM, continuous glucose monitor, Arden, Arden's Day, Scott Benner, JDRF, diabetes, juvenile diabetes, daddy blog, blog, stay at home parent, DOC, twitter, Facebook, @ardensday, 504 plan, Life Is Short, Laundry Is Eternal, Dexcom SHARE, 生命是短暂的,洗衣是永恒的, Shēngmìng shì duǎnzàn de, xǐyī shì yǒnghéng de

Filtering by Tag: type 2


Scott Benner


Thank you for listening to the Juicebox Podcast and for supporting our sponsor OmniPod. I can't believe that the podcast has already reached so many people. I would like to thank each of you for subscribing, listening and for spreading the word. A special shoutout to those of you who have shared your experiences. Your candid and brave descriptions of your life with diabetes have strengthened the diabetes community and added to its advocacy and awareness. I have been honored to speak with each of you and look forward to much more in the future! 

For those of you who haven't checked out the podcast.... c'mon 50,000 people can't all be wrong. Subscribe in iTunes, listen online, read a review. All you need is a browser or a podcast app (iPhone users, the app is already on your phone - just search 'Juicebox Podcast' and start listening today.

Available everywhere podcasts are found.... coming soon to the Google Play store.

Tracy Morgan loves to show his Diabetes Technology

Scott Benner

Words aren't needed. From the Late Show March 30, 2016.

You Can Help to Create CGM Medicare Coverage

Scott Benner

If you speak up, things will change!

I am a huge proponent of continuous glucose monitoring and believe that everyone deserves it's benefits and protection if they want it. Please take a moment to help the JDRF give a friendly push to our legislators. Doing the right thing for older people who have type 1 diabetes is the least that should be done. Your participation only takes a few moments and I've seen the JDRF's actions help issues like this in the past. If you speak up, things will change! Thank you, Scott

Word for word from

One Voice Calling for Medicare Coverage of Continuous Glucose Monitors (CGMs)

We need your help. Ask the U.S. Senate and U.S. House of Representatives to cosponsor bipartisan bills to ensure people over 65, and who are Medicare-eligible, have access to life-saving CGMs!

The Co-Chairs of the Senate Diabetes Caucus have reintroduced important bipartisan legislation (S. 804)
—the “Medicare CGM Access Act of 2015”—that would facilitate Medicare coverage for continuous glucose monitors (CGMs) and help pave the way for the next generation of CGM-related technologies, such as artificial pancreas (AP) systems.

This legislation now joins a bipartisan companion bill, (H.R. 1427), the “Medicare CGM Access Act of 2015,” introduced in the U.S. House by the leadership of the Congressional Diabetes Caucus.

But we still need your help! Please take a few minutes to:

  1. Email your Representatives and ask them to support H.R. 1427, the “Medicare CGM Access Act of 2015.”
  2. Email your Senators and ask that they support S. 804, the “Medicare CGM Access Act of 2015.”

After you complete these two simple action steps, please ask your friends, family, neighbors and coworkers to do the same! And spread the word on your favorite social media pages using the hashtag #MedicareCoverCGM.

Why CGMS should be covered by Medicare

CGMs are FDA-approved, physician-prescribed devices that detect and display blood-glucose levels continuously—and reveal trends in these levels that often go unnoticed. A JDRF-funded CGM trial has shown that the rate of severe high blood-sugar (hypoglycemia) events among adults using a CGM fell by two-thirds over the first year of use. Not surprisingly, CGMs are recommended by national diabetes clinical guidelines—and they’re covered by nearly all private health plans. 

Unfortunately, Medicare does not currently cover CGMs—despite the evidence of clinical benefit. The result? Millions of seniors with diabetes are left vulnerable to severe low blood-sugar (hyperglycemia) events that can lead to seizures, bouts of unconsciousness and hospitalization. And the costs are not just physical:

  • Hypoglycemia inpatient admission rates are an average of $17,564 per visit.
  • Diabetes is one of the costliest chronic diseases, accounting for $245 billion in economic losses in 2012, including $176 billion in direct medical costs.
  • Of that $176 billion, 59 percent is attributed to those ages 65 and older.
  • Overall, 42 percent of Medicare fee-for-service spending is attributed to people with diabetes.

JDRF has been working closely with other interested stakeholders to encourage Medicare to cover CGM devices—and we have made it one of our top national advocacy priorities. While we continue to work to resolve this issue quickly, we need your help to build support within Congress.

Please take action today!

Remember, all you have to do is: 

  1. Ask the U.S. House to co-sponsor H.R. 1427
  2. Ask the U.S. Senate to co-sponsor S. 804

Dexcom Announces Google Collaboration

Scott Benner

Dexcom to Collaborate with the Life Sciences Team at Google on the Development of Breakthrough Technologies to Change the Future of Diabetes Management 

Press Release - August 11, 2015

The full press release is here... but these are the parts you care about...

This partnership has the potential to change the face of diabetes technology forever
— Kevin Sayer, President and Chief Executive Officer of Dexcom
Working together, we believe we can introduce products that will move us beyond our core Type 1 business to become the standard of care for all people living with diabetes
— Kevin Sayer

Initial products to be developed under the agreement will focus on minimizing both the cost and size of CGM body worn components. The products will be designed to be disposable, and will be intended for use across all diabetes markets. The goal is to empower more people to control their diabetes with real-time and actionable information by developing a low-cost, small, bandage-sized sensor that is connected to the cloud. By addressing these needs, we believe we will have the platform that can replace finger sticks and become the standard of care.
— Dexcom Press Release
Kevin Sayer

Kevin Sayer

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it has entered into an agreement with the life sciences team at Google to jointly develop a series of next-generation CGM products that are designed to be smaller and less expensive than existing technologies. These new products will incorporate Google's miniaturized electronics platform with DexCom's best-in-class sensor technology. This collaboration also provides an opportunity to better utilize the data generated by these CGM products to significantly improve the outcomes and reduce the costs associated with diabetes care. 

I spoke with Kevin a few days after this announcement for the Juicebox Podcast. It's a great listen if you are interested in Dexcom technology. The show is available on iTunes and wherever you find your podcasts. You can also listen here with this player.

Take the Type 2 Diabetes Risk Test

Scott Benner

from: American Diabetes Association

Diabetes is a serious disease that strikes nearly 30 million children and adults in the United States, and more than a quarter of them—eight million—do not even know they have it. An additional 86 million have prediabetes, which puts them at high risk for developing type 2 diabetes. Unfortunately, diagnosis often comes 7 to 10 years after the onset of the disease, after disabling and even deadly complications have had time to develop. Therefore, early diagnosis is critical to successful treatment and delaying or preventing some of these complications such as heart disease, blindness, kidney disease, stroke, amputation and death. 

Who should participate in Alert Day?

Everyone should be aware of the risk factors for type 2 diabetes. People who are overweight, under active (living a sedentary lifestyle) and over the age of 45 should consider themselves at risk for the disease. African Americans, Hispanics/Latinos, Native Americans, Asian Americans, Pacific Islanders and people who have a family history of the disease also are at an increased risk for developing type 2 diabetes. Studies have shown that type 2 diabetes can often be prevented or delayed by losing just 7 percent of body weight (such as 15 pounds if you weigh 200) through regular physical activity (30 minutes a day, five days a week) and healthy eating. By understanding your risk, you can take the necessary steps to help prevent the onset of type 2 diabetes. 

Click on the image to take the test